105 related articles for article (PubMed ID: 11999131)
1. Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer.
Kato Y; Onishi H; Machida Y
J Pharm Pharmacol; 2002 Apr; 54(4):529-37. PubMed ID: 11999131
[TBL] [Abstract][Full Text] [Related]
2. Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis.
Kato Y; Onishi H; Machida Y
Int J Pharm; 2001 Sep; 226(1-2):93-106. PubMed ID: 11532574
[TBL] [Abstract][Full Text] [Related]
3. Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice.
Kato Y; Onishi H; Machida Y
J Control Release; 2001 Feb; 70(3):295-307. PubMed ID: 11182200
[TBL] [Abstract][Full Text] [Related]
4. Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice.
Kato Y; Onishi H; Machida Y
Biol Pharm Bull; 2000 Dec; 23(12):1497-503. PubMed ID: 11145185
[TBL] [Abstract][Full Text] [Related]
5. Tumour cell uptake of lactosaminated and intact N-succinyl-chitosans and antitumour effects of conjugates with mitomycin C.
Kato Y; Onishi H; Machida Y
Anticancer Res; 2002; 22(5):2771-6. PubMed ID: 12529995
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
Song Y; Onishi H; Nagai T
Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
[TBL] [Abstract][Full Text] [Related]
7. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
Kato Y; Onishi H; Machida Y
Biomaterials; 2004 Feb; 25(5):907-15. PubMed ID: 14609679
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin.
Song Y; Onishi H; Nagai T
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2822-5. PubMed ID: 1464115
[TBL] [Abstract][Full Text] [Related]
9. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Takahara J; Machida Y; Nagai T
Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro properties of N-succinylchitosan- or carboxymethylchitin-mitomycin C conjugate microparticles with specified size.
Onishi H; Takahashi H; Yoshiyasu M; Machida Y
Drug Dev Ind Pharm; 2001 Aug; 27(7):659-67. PubMed ID: 11694013
[TBL] [Abstract][Full Text] [Related]
11. Biodisposition characteristics of N-succinyl-chitosan and glycol-chitosan in normal and tumor-bearing mice.
Kamiyama K; Onishi H; Machida Y
Biol Pharm Bull; 1999 Feb; 22(2):179-86. PubMed ID: 10077438
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer.
Kato Y; Onishi H; Machida Y
Biomaterials; 2000 Aug; 21(15):1579-85. PubMed ID: 10885730
[TBL] [Abstract][Full Text] [Related]
13. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Kitano M; Machida Y; Nagai T
Biol Pharm Bull; 1996 Feb; 19(2):241-5. PubMed ID: 8850315
[TBL] [Abstract][Full Text] [Related]
14. Application of chitin and chitosan derivatives in the pharmaceutical field.
Kato Y; Onishi H; Machida Y
Curr Pharm Biotechnol; 2003 Oct; 4(5):303-9. PubMed ID: 14529420
[TBL] [Abstract][Full Text] [Related]
15. In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.
Yan C; Gu J; Guo Y; Chen D
Yakugaku Zasshi; 2010 Jun; 130(6):801-4. PubMed ID: 20519858
[TBL] [Abstract][Full Text] [Related]
16. Contribution of chitosan and its derivatives to cancer chemotherapy.
Kato Y; Onishi H; Machida Y
In Vivo; 2005; 19(1):301-10. PubMed ID: 15796190
[TBL] [Abstract][Full Text] [Related]
17. [Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm].
Chen LJ; Zhang SY; Zhang JL; Zhang Z; Li S; Chen M; Zhang XY; Chen XT
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):572-6. PubMed ID: 8010062
[TBL] [Abstract][Full Text] [Related]
18. Distribution and excretion of 7-N-(p-hydroxyphenyl)-mitomycin C in normal mice.
Imai R; Morimoto M; Marumo H
Gan; 1982 Aug; 73(4):675-80. PubMed ID: 6818093
[TBL] [Abstract][Full Text] [Related]
19. [Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice].
Zhang SY; Li S; Chen LJ; Shu YH; Zhang XY; Chen XT
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):556-60. PubMed ID: 2130622
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
